Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial

Sherko Kuemmel,Johannes Holtschmidt,Bernd Gerber,Albert von der Assen,Joerg Heil,Marc Thill,David Krug,Christian Schem,Carsten Denkert,Juliane Lubitz,Jens-Uwe Blohmer,Mattea Reinisch,Michael Hötzeldt,Fenja Seither,Valentina Nekljudova,Ilka Schwidde,Klara Uhrhan,Gunter von Minckwitz,Mahdi Rezai,Jana Mulowski,Sibylle Loibl,Thorsten Kuehn

Prospective, Multicenter, Randomized Phase III Trial Evaluating the Impact of Lymphoscintigraphy as Part of Sentinel Node Biopsy in Early Breast Cancer: SenSzi (GBG80) Trial

2019

PURPOSEThe aim of the current work was to clarify whether a preoperative lymphoscintigraphy (LSG) enhances staging accuracy of sentinel lymph node biopsy (SLNB).PATIENTS AND METHODSIn a prospective...

Keywords:

Breast cancer
Radiology
Pathology
Sentinel lymph node
Biopsy
Sentinel node
Stage (cooking)
Medicine
early breast cancer

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations